{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:30:49Z","timestamp":1770525049822,"version":"3.49.0"},"reference-count":56,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013743","name":"World Cancer Research Fund International","doi-asserted-by":"publisher","award":["2014\/1179"],"award-info":[{"award-number":["2014\/1179"]}],"id":[{"id":"10.13039\/100013743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013743","name":"World Cancer Research Fund International","doi-asserted-by":"publisher","award":["IIG_FULL_2021_022"],"award-info":[{"award-number":["IIG_FULL_2021_022"]}],"id":[{"id":"10.13039\/100013743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013743","name":"World Cancer Research Fund International","doi-asserted-by":"publisher","award":["IIG_FULL_2021_023"],"award-info":[{"award-number":["IIG_FULL_2021_023"]}],"id":[{"id":"10.13039\/100013743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013743","name":"World Cancer Research Fund International","doi-asserted-by":"publisher","award":["IIG_FULL_2023_017"],"award-info":[{"award-number":["IIG_FULL_2023_017"]}],"id":[{"id":"10.13039\/100013743","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regio Deal Foodvalley","award":["162135"],"award-info":[{"award-number":["162135"]}]},{"name":"ERA-NET on Translational Cancer Research (TRANSCAN: Dutch Cancer Society and the Netherlands Organization for Health Research and Development","award":["UW 2013-6397"],"award-info":[{"award-number":["UW 2013-6397"]}]},{"name":"ERA-NET on Translational Cancer Research (TRANSCAN: Dutch Cancer Society and the Netherlands Organization for Health Research and Development","award":["UW 2014-6877"],"award-info":[{"award-number":["UW 2014-6877"]}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UM 2012-5653"],"award-info":[{"award-number":["UM 2012-5653"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UW 2013-5927"],"award-info":[{"award-number":["UW 2013-5927"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UW 2015-7946"],"award-info":[{"award-number":["UW 2015-7946"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjonc"],"accepted":{"date-parts":[[2024,7,30]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Chronic chemotherapy-induced peripheral neuropathy (CIPN) is a long-lasting side-effect of oxaliplatin. Vitamin B6 might play a role in the pathogenesis of CIPN. Therefore, we investigated associations between plasma vitamin B6 markers and the occurrence and severity of chronic CIPN in patients with non-metastatic colorectal cancer (CRC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>242 patients with CRC receiving oxaliplatin-based chemotherapy were included. Blood samples were collected at diagnosis (ie, before chemotherapy), and 6 and 12 months after diagnosis (ie, during and after chemotherapy, respectively). Pyridoxal 5\u2032-phosphate (PLP), pyridoxal (PL) and xanthurenic acid:3-hydroxykynurenine (XA:HK) ratio were measured as vitamin B6 markers using liquid chromatography tandem mass spectrometry. Chronic CIPN was assessed 12 months after diagnosis using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-CIPN twenty-item scale questionnaire. Prevalence ratios (PRs) and restricted cubic splines (RCSs) were used to assess associations with chronic CIPN occurrence, and linear regressions were used to assess associations with chronic CIPN severity. Analyses were adjusted for age, sex, smoking, alcohol consumption, diabetes and timing of chemotherapy (neoadjuvant\/adjuvant\/both).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Chronic CIPN was found in 80% (n=194) of patients. Higher PLP levels and XA:HK ratios during chemotherapy were associated with lower occurrence of chronic CIPN (PR<jats:sub>perdoubling<\/jats:sub> 0.75, 95% CI 0.62 to 0.91 and P<jats:sub>RCS<\/jats:sub>&lt;0.05, respectively) and lower chronic CIPN severity (\u03b2<jats:sub>perdoubling<\/jats:sub> \u22124.54, 95% CI \u22127.12 to \u22121.96 and \u03b2<jats:sub>perdoubling<\/jats:sub> \u22126.30, 95% CI \u22129.53 to \u22123.07, respectively). No associations between PL levels and chronic CIPN were observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Within this population, merely having PLP levels within the normal range, higher vitamin B6 status during chemotherapy was associated with lower occurrence and severity of chronic CIPN. Future research is warranted to investigate causality and the optimal vitamin B6 status during chemotherapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjonc-2024-000462","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:32:09Z","timestamp":1723163529000},"page":"e000462","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy"],"prefix":"10.1136","volume":"3","clinical-trial-number":[{"clinical-trial-number":"nct03191110","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Lisanne","family":"Renting","sequence":"first","affiliation":[{"name":"Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0619-9248","authenticated-orcid":false,"given":"Nienke R K","family":"Zwart","sequence":"additional","affiliation":[{"name":"Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Magne","family":"Ueland","sequence":"additional","affiliation":[{"name":"BEVITAL AS, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"McCann","sequence":"additional","affiliation":[{"name":"BEVITAL AS, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arve","family":"Ulvik","sequence":"additional","affiliation":[{"name":"BEVITAL AS, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk K","family":"van Halteren","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Admiraal de Ruyter Hospital, Goes, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floor J E","family":"Lubberman","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hospital Gelderse Vallei, Ede, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate M","family":"Winkels","sequence":"additional","affiliation":[{"name":"Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Kampman","sequence":"additional","affiliation":[{"name":"Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-8207","authenticated-orcid":false,"given":"Dieuwertje E","family":"Kok","sequence":"additional","affiliation":[{"name":"Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"2025090109102061000_3.1.e000462.1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32319-0"},{"key":"2025090109102061000_3.1.e000462.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.003"},{"key":"2025090109102061000_3.1.e000462.3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr524"},{"key":"2025090109102061000_3.1.e000462.4","first-page":"732","article-title":"Peripheral Neuropathy: Evaluation and Differential Diagnosis","volume":"102","author":"Castelli","year":"2020","journal-title":"Am Fam Physician"},{"key":"2025090109102061000_3.1.e000462.5","first-page":"95","article-title":"Exploring the relationship among dispositional optimism, health-related quality of life, and CIPN severity among colorectal cancer patients with chronic peripheral neuropathy","volume":"30","author":"Trompetter","year":"2022","journal-title":"Support Care Cancer"},{"key":"2025090109102061000_3.1.e000462.6","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2014.995775"},{"key":"2025090109102061000_3.1.e000462.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06502-4"},{"key":"2025090109102061000_3.1.e000462.8","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000404"},{"key":"2025090109102061000_3.1.e000462.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.8533"},{"key":"2025090109102061000_3.1.e000462.10","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0248"},{"key":"2025090109102061000_3.1.e000462.11","doi-asserted-by":"crossref","first-page":"103122","DOI":"10.1016\/j.critrevonc.2020.103122","article-title":"Management of pain in colorectal cancer patients","volume":"157","author":"Zieli\u0144ska","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025090109102061000_3.1.e000462.12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11864-021-00926-0","article-title":"Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy","volume":"23","author":"Mezzanotte","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"2025090109102061000_3.1.e000462.13","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-017-0636-z","article-title":"B Vitamin Complex and Chemotherapy-Induced Peripheral Neuropathy","volume":"19","author":"Schloss","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"2025090109102061000_3.1.e000462.14","doi-asserted-by":"crossref","first-page":"136606","DOI":"10.1016\/j.foodchem.2023.136606","article-title":"The importance, prevalence and determination of vitamins B6 and B12 in food matrices: A review","volume":"426","author":"Santos","year":"2023","journal-title":"Food Chem"},{"key":"2025090109102061000_3.1.e000462.15","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13207"},{"key":"2025090109102061000_3.1.e000462.16","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000049"},{"key":"2025090109102061000_3.1.e000462.17","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24969"},{"key":"2025090109102061000_3.1.e000462.18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jsps.2023.03.005","article-title":"Impact of vitamin B6 deficiency on the severity of diabetic peripheral neuropathy - A cross sectional study","volume":"31","author":"Khobrani","year":"2023","journal-title":"Saudi Pharm J"},{"key":"2025090109102061000_3.1.e000462.19","first-page":"195","article-title":"A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)","volume":"25","author":"Schloss","year":"2017","journal-title":"Support Care Cancer"},{"key":"2025090109102061000_3.1.e000462.20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3126\/ajms.v9i1.18510","article-title":"Management of peripheral neuropathy symptoms with a fixed dose combination of high-dose vitamin B1, B6 and B12: a 12-week prospective non-interventional study in Indonesia","volume":"9","author":"Hakim","year":"2018","journal-title":"Asian J Med Sci"},{"key":"2025090109102061000_3.1.e000462.21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/advances\/nmab033","article-title":"Vitamin B-6-Induced Neuropathy: Exploring the Mechanisms of Pyridoxine Toxicity","volume":"12","author":"Hadtstein","year":"2021","journal-title":"Adv Nutr"},{"key":"2025090109102061000_3.1.e000462.22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tiv.2017.07.009","article-title":"The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function","volume":"44","author":"Vrolijk","year":"2017","journal-title":"Toxicol In Vitro"},{"key":"2025090109102061000_3.1.e000462.23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40264-018-0664-0","article-title":"Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases","volume":"41","author":"van Hunsel","year":"2018","journal-title":"Drug Saf"},{"key":"2025090109102061000_3.1.e000462.24","first-page":"43","article-title":"A Narrative Review of Complementary Nutritional Supplements for Chemotherapy-induced Peripheral Neuropathy","volume":"26","author":"Liu","year":"2020","journal-title":"Altern Ther Health Med"},{"key":"2025090109102061000_3.1.e000462.25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-374","article-title":"The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of life","volume":"14","author":"Winkels","year":"2014","journal-title":"BMC Cancer"},{"key":"2025090109102061000_3.1.e000462.26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-071714-034330"},{"key":"2025090109102061000_3.1.e000462.27","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.4013"},{"key":"2025090109102061000_3.1.e000462.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.02.012"},{"key":"2025090109102061000_3.1.e000462.29","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0379-8"},{"key":"2025090109102061000_3.1.e000462.30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2016.09.020","article-title":"Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population","volume":"69","author":"Mols","year":"2016","journal-title":"Eur J Cancer"},{"key":"2025090109102061000_3.1.e000462.31","doi-asserted-by":"publisher","DOI":"10.1177\/109442819923001"},{"key":"2025090109102061000_3.1.e000462.32","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-6-57","article-title":"Dealing with missing data in a multi-question depression scale: a comparison of imputation methods","volume":"6","author":"Shrive","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"2025090109102061000_3.1.e000462.33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.ejcn.1602581","article-title":"Validation of the assessment of folate and vitamin B12 intake in women of reproductive age: the method of triads","volume":"61","author":"Verkleij-Hagoort","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"2025090109102061000_3.1.e000462.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.05.008"},{"key":"2025090109102061000_3.1.e000462.35","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7059"},{"key":"2025090109102061000_3.1.e000462.36","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1312","article-title":"Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy","volume":"9","author":"Molassiotis","year":"2019","journal-title":"Brain Behav"},{"key":"2025090109102061000_3.1.e000462.37","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0418"},{"key":"2025090109102061000_3.1.e000462.38","doi-asserted-by":"publisher","DOI":"10.3945\/jn.114.203091"},{"key":"2025090109102061000_3.1.e000462.39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.744085","article-title":"Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients\u2019 Profiles With Oxaliplatin-Induced Peripheral Neuropathy","volume":"12","author":"Kerckhove","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025090109102061000_3.1.e000462.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.020"},{"key":"2025090109102061000_3.1.e000462.41","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S125987"},{"key":"2025090109102061000_3.1.e000462.42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01637"},{"key":"2025090109102061000_3.1.e000462.43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jns.12480","article-title":"Vitamin B6 levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy","volume":"27","author":"Stewart","year":"2022","journal-title":"J Peripher Nerv Syst"},{"key":"2025090109102061000_3.1.e000462.44","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji116"},{"key":"2025090109102061000_3.1.e000462.45","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0459"},{"key":"2025090109102061000_3.1.e000462.46","article-title":"Scientific opinion on the tolerable upper intake level for vitamin B6","volume":"21","author":"Turck","year":"2023","journal-title":"EFSA J"},{"key":"2025090109102061000_3.1.e000462.47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","article-title":"Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy","volume":"2","author":"Areti","year":"2014","journal-title":"Redox Biol"},{"key":"2025090109102061000_3.1.e000462.48","doi-asserted-by":"publisher","DOI":"10.2217\/pmt.15.19"},{"key":"2025090109102061000_3.1.e000462.49","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-10-273","article-title":"The B6 database: A tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein families","volume":"10","author":"Percudani","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"2025090109102061000_3.1.e000462.50","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9968228","article-title":"The Role of Neurotropic B Vitamins in Nerve Regeneration","volume":"2021","author":"Baltrusch","year":"2021","journal-title":"Biomed Res Int"},{"key":"2025090109102061000_3.1.e000462.51","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ajcn\/87.5.1446","article-title":"Plasma pyridoxal 5\u2019-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004","volume":"87","author":"Morris","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"2025090109102061000_3.1.e000462.52","first-page":"2398","article-title":"Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non\u2011alcoholic fatty liver disease mouse model","volume":"43","author":"Lu","year":"2019","journal-title":"Int J Mol Med"},{"key":"2025090109102061000_3.1.e000462.53","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1017\/S0007114515001798","article-title":"Dietary changes and dietary supplement use, and underlying motives for these habits reported by colorectal cancer survivors of the Patient Reported Outcomes Following Initial Treatment and Long-Term Evaluation of Survivorship (PROFILES) registry","volume":"114","author":"Bours","year":"2015","journal-title":"Br J Nutr"},{"key":"2025090109102061000_3.1.e000462.54","first-page":"2039","article-title":"The determinants of reduced dietary intake in hospitalised colorectal cancer patients","volume":"26","author":"van der Werf","year":"2018","journal-title":"Support Care Cancer"},{"key":"2025090109102061000_3.1.e000462.55","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21204"},{"key":"2025090109102061000_3.1.e000462.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.04.001"}],"container-title":["BMJ Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjonc-2024-000462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:10:34Z","timestamp":1756743034000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjoncology.bmj.com\/lookup\/doi\/10.1136\/bmjonc-2024-000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,8]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/bmjonc-2024-000462"],"URL":"https:\/\/doi.org\/10.1136\/bmjonc-2024-000462","relation":{},"ISSN":["2752-7948"],"issn-type":[{"value":"2752-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}